Mark Higgins

4.4k citations
73 papers · 2.8k indexed · 1 hit paper · h-index 26

Impact in

    • Cystic Fibrosis Research Advances
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Neonatal Respiratory Health Research
    • Inhalation and Respiratory Drug Delivery
    • Respiratory Support and Mechanisms
    • Tracheal and airway disorders
    • Respiratory and Cough-Related Research
  • Physiology top 2%
    • Asthma and respiratory diseases

Papers in

    • Cystic Fibrosis Research Advances 25
    • Inhalation and Respiratory Drug Delivery 22
    • Chronic Obstructive Pulmonary Disease (COPD) Research 21
    • Respiratory Support and Mechanisms 14
    • Respiratory and Cough-Related Research 10
    • Neonatal Respiratory Health Research 5
    • Asthma and respiratory diseases 23

Mark Higgins

67 papers receiving 2.7k citations

Hit Papers

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation 2014 · 277 citations
277201420262018202250100150200250

Peers

Mark Higgins
Comparison fields: 5 of 116
  • Pulmonary and Respiratory Medicine 2.4k
  • Physiology 1.2k
  • Molecular Medicine 49
  • Issues, ethics and legal aspects 12
  • Emergency Medical Services 59
Replace Thomas J. Hwang with:
Thomas J. Hwang United States
Michael P. Douglas United States
Catherine H. Marshall United States
Stephen J. Jay United States
Christine Pierre United States
Edward D. Lustbader United States
Mark R. Wakefield United States
Birgitta Olsson Sweden
Lan Liu China
Mark Higgins relative to Thomas J. Hwang United States Thomas J. Hwang's profile →
Citations per field
00.5×10×20×27.1×
Thomas J. Hwang · 1×
Citations per year

Countries citing papers authored by Mark Higgins

Since Specialization
Citations

This map shows the geographic impact of Mark Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Higgins more than expected).

Fields of papers citing papers by Mark Higgins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Higgins. The network helps show where Mark Higgins may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Higgins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Higgins Line = papers co-authored together Mark Higgins links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20248
2 20240
3 202220
4 202011
5 201925
6 201737
7 201431
8
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
Hit paper breakdown →
2014277
9 201413
10 2010273
11 2010255
12 201023
13 201024
14 2010101
15 200871
16
The Value Impact of Strategic Intent on Firms Engaged in Information Systems Outsourcing
20084
17 200721
18 200736
19 200667
20
On the Answer-Arrangement Bias of Professional Certification Examinations in Accounting
19975

About Mark Higgins

Mark Higgins is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Accounting, Emergency Medical Services and Animal Science and Zoology, having authored 73 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (25 papers), Asthma and respiratory diseases (23 papers), Inhalation and Respiratory Drug Delivery (22 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers), Respiratory Support and Mechanisms (14 papers), Respiratory and Cough-Related Research (10 papers), Nematode management and characterization studies (5 papers) and Neonatal Respiratory Health Research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.4k citations), Physiology (1.2k citations), Molecular Medicine (49 citations), Issues, ethics and legal aspects (12 citations) and Emergency Medical Services (59 citations). Mark Higgins has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Roger Owen, Benjamin Krämer, Damon Jack, Michael W. Konstan, Patrick A. Flume, K. De Boeck, À. Munck, Amir Iqbal, Geoffrey Gilmartin and Seth Walker. Their work appears in journals such as Journal of Cystic Fibrosis, Respiratory Medicine, Current Medical Research and Opinion, Pulmonary Pharmacology & Therapeutics and Thorax.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026